A Randomized Phase II Study of a PSA-Based Vaccine in Patients With Localized Prostate Cancer Receiving Standard Radiotherapy.
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Prostate cancer vaccine (Primary) ; Aldesleukin; Granulocyte-macrophage colony-stimulating factors
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 16 Aug 2006 Status change
- 12 Oct 2005 New trial record.